The global hyaluronic acid raw material market size was estimated to be USD 7.05 billion in 2023 and is expected to reach at USD 14.23 billion by 2034 with a CAGR of 6.59% during the forecast period 2024-2034. Enlarging geriatric population, surge in introduction of technologically advanced products, rising number of aesthetic procedures, growing prevalence of eye-related disorders & osteoarthritis, increase in number of surgeries performed, surge in investment for new product development, rising demand for anti-aging solutions, growing adoption of minimally invasive aesthetic treatments, increasing product launches, surge in regulatory approvals of hyaluronic acid-based products are the factors contributing to the market's growth.
Surge in regulatory approvals of hyaluronic acid-based products is predicted to boost the market growth during the forecast period. Hyaluronic acid is a common ingredient in dermal fillers used for facial aesthetics, including wrinkle reduction and lip augmentation. The increasing trend in non-surgical cosmetic treatments and the changing preferences of consumers towards facial rejuvenation are expected to drive up the demand for hyaluronic acid in dermal filler applications. For instance, in June 2023, Galderma, a company specializing in skincare and dermatological products, has announced that Restylane Eyelight has received approval from the U.S. Food and Drug Administration (FDA). This approval allows the use of Restylane Eyelight for the treatment of undereye hollows, commonly known as dark shadows, in adults aged 21 and older. Restylane Eyelight is an under-eye dermal filler made with hyaluronic acid (HA) and is unique in the U.S. market because it incorporates NASHA Technology. The incorporation of NASHA Technology is designed to address volume loss in the undereye area, providing patients with natural-looking results.
By grade, pharmaceutical was the highest revenue-grossing segment in the global hyaluronic acid raw material market in 2023 owing to the pharmaceutical industry is increasingly using hyaluronic acid due to its unique properties, including its ability to retain water, lubricate joints, & provide cushioning, surge in spending on hyaluronic acid-based drugs & novel formulations by pharmaceutical companies, growing awareness regarding the therapeutic potential of hyaluronic acid, and rising focus on the development of novel pharmaceutical formulations. Additionally, cosmetic is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for hyaluronic acid raw materials as consumers prioritize skincare & look for products that provide hydration, anti-aging benefits, & rejuvenating properties, rising use of hyaluronic acid raw material in cosmetics, surge in aging population, increasing awareness of skincare, and growing launch of new products. For instance, in August 2022, Iris and Romeo have introduced the Reset Hyaluronic Acid + Niacinamide Serum Spray, an all-in-one serum spray designed to plump the skin. It combines niacinamide, ceramides, and hyaluronic acid, increasing cell membrane fluidity by 40%, resulting in visibly plumper skin.
By application, orthopedics was the highest revenue-grossing segment in the global hyaluronic acid raw material market in 2023 owing to the increasing adoption of technologically advanced drugs, growing use of hyaluronic acid for the osteoarthritis treatment procedures, surge in prevalence of arthritis, and rising approvals of therapeutic products. Additionally, drug delivery is predicted to grow at fastest CAGR during the forecast period owing to the surge in research & development activities, increasing demand for innovative medication delivery systems. For instance, in May 2023, Allergan Aesthetics, a subsidiary of AbbVie, has revealed that the U.S. FDA has approved SKINVIVE by JUVÉDERM for enhancing skin smoothness in the cheeks of adults aged 21 and older. SKINVIVE by JUVÉDERM is the first and only hyaluronic acid (HA) intradermal microdroplet injection for achieving skin smoothness in the U.S., and its results can last for up to six months with optimal treatment.
By end-user, hospitals was the highest revenue-grossing segment in the global hyaluronic acid raw material market in 2023. Hospitals function as primary healthcare facilities that have the capacity to provide patients with comprehensive orthopedic care, growing prevalence of osteoarthritis, and rising introduction of new products by market players. For instance, in March 2022, NovaBay Pharmaceuticals has introduced the Moisture Recovery HA Serum as the latest addition to the Calm Cool + Corrected product line. This serum features an innovative blend of hyaluronic acid, vitamin C, dragon fruit, and water-binding cactus botanicals, designed to rejuvenate dehydrated skin and enhance the absorption of other skincare-healing products. Additionally, cosmetic clinics is predicted to grow at fastest CAGR during the forecast period owing to the increasing focus on treating various skin conditions, these healthcare environments play a vital role in delivering effective hyaluronic acid treatments to patients.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in introduction of advanced technologies, rising healthcare infrastructure, growing patient awareness regarding to the availability of aesthetic & anti-aging procedures, increasing demand for minimally invasive cosmetic procedures, and surge in focus on developing hyaluronic acid-related products. For instance, in August 2022, Versed has unveiled an anti-aging serum called Versed Moisture Maker, enriched with hyaluronic acid. This serum is designed to provide users with silky, soft, and resilient skin. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing awareness of skincare routines, rising adoption of hyaluronic acid in cosmetic procedures, increasing prevalence of orthopaedic disorders such as osteoarthritis, arthritis, & knee pain, surge in geriatric population, and growing introduction of innovative products. For instance, in August 2022, Laneige has introduced the Water Bank Hyaluronic range in India. This range is designed to help maintain moisture and promote healthier, more supple skin. It comprises 11 products, including cleansing oil, cleansing foam, toner, and essence.
Surge in regulatory approvals of hyaluronic acid-based products is predicted to boost the market growth during the forecast period. Hyaluronic acid is a common ingredient in dermal fillers used for facial aesthetics, including wrinkle reduction and lip augmentation. The increasing trend in non-surgical cosmetic treatments and the changing preferences of consumers towards facial rejuvenation are expected to drive up the demand for hyaluronic acid in dermal filler applications. For instance, in June 2023, Galderma, a company specializing in skincare and dermatological products, has announced that Restylane Eyelight has received approval from the U.S. Food and Drug Administration (FDA). This approval allows the use of Restylane Eyelight for the treatment of undereye hollows, commonly known as dark shadows, in adults aged 21 and older. Restylane Eyelight is an under-eye dermal filler made with hyaluronic acid (HA) and is unique in the U.S. market because it incorporates NASHA Technology. The incorporation of NASHA Technology is designed to address volume loss in the undereye area, providing patients with natural-looking results.
By grade, pharmaceutical was the highest revenue-grossing segment in the global hyaluronic acid raw material market in 2023 owing to the pharmaceutical industry is increasingly using hyaluronic acid due to its unique properties, including its ability to retain water, lubricate joints, & provide cushioning, surge in spending on hyaluronic acid-based drugs & novel formulations by pharmaceutical companies, growing awareness regarding the therapeutic potential of hyaluronic acid, and rising focus on the development of novel pharmaceutical formulations. Additionally, cosmetic is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for hyaluronic acid raw materials as consumers prioritize skincare & look for products that provide hydration, anti-aging benefits, & rejuvenating properties, rising use of hyaluronic acid raw material in cosmetics, surge in aging population, increasing awareness of skincare, and growing launch of new products. For instance, in August 2022, Iris and Romeo have introduced the Reset Hyaluronic Acid + Niacinamide Serum Spray, an all-in-one serum spray designed to plump the skin. It combines niacinamide, ceramides, and hyaluronic acid, increasing cell membrane fluidity by 40%, resulting in visibly plumper skin.
By application, orthopedics was the highest revenue-grossing segment in the global hyaluronic acid raw material market in 2023 owing to the increasing adoption of technologically advanced drugs, growing use of hyaluronic acid for the osteoarthritis treatment procedures, surge in prevalence of arthritis, and rising approvals of therapeutic products. Additionally, drug delivery is predicted to grow at fastest CAGR during the forecast period owing to the surge in research & development activities, increasing demand for innovative medication delivery systems. For instance, in May 2023, Allergan Aesthetics, a subsidiary of AbbVie, has revealed that the U.S. FDA has approved SKINVIVE by JUVÉDERM for enhancing skin smoothness in the cheeks of adults aged 21 and older. SKINVIVE by JUVÉDERM is the first and only hyaluronic acid (HA) intradermal microdroplet injection for achieving skin smoothness in the U.S., and its results can last for up to six months with optimal treatment.
By end-user, hospitals was the highest revenue-grossing segment in the global hyaluronic acid raw material market in 2023. Hospitals function as primary healthcare facilities that have the capacity to provide patients with comprehensive orthopedic care, growing prevalence of osteoarthritis, and rising introduction of new products by market players. For instance, in March 2022, NovaBay Pharmaceuticals has introduced the Moisture Recovery HA Serum as the latest addition to the Calm Cool + Corrected product line. This serum features an innovative blend of hyaluronic acid, vitamin C, dragon fruit, and water-binding cactus botanicals, designed to rejuvenate dehydrated skin and enhance the absorption of other skincare-healing products. Additionally, cosmetic clinics is predicted to grow at fastest CAGR during the forecast period owing to the increasing focus on treating various skin conditions, these healthcare environments play a vital role in delivering effective hyaluronic acid treatments to patients.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in introduction of advanced technologies, rising healthcare infrastructure, growing patient awareness regarding to the availability of aesthetic & anti-aging procedures, increasing demand for minimally invasive cosmetic procedures, and surge in focus on developing hyaluronic acid-related products. For instance, in August 2022, Versed has unveiled an anti-aging serum called Versed Moisture Maker, enriched with hyaluronic acid. This serum is designed to provide users with silky, soft, and resilient skin. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing awareness of skincare routines, rising adoption of hyaluronic acid in cosmetic procedures, increasing prevalence of orthopaedic disorders such as osteoarthritis, arthritis, & knee pain, surge in geriatric population, and growing introduction of innovative products. For instance, in August 2022, Laneige has introduced the Water Bank Hyaluronic range in India. This range is designed to help maintain moisture and promote healthier, more supple skin. It comprises 11 products, including cleansing oil, cleansing foam, toner, and essence.
Segmentation: Hyaluronic Acid Raw Material Market Report 2023 - 2034
Hyaluronic Acid Raw Material Market Analysis & Forecast by Grade 2023 - 2034 (Revenue USD Bn)
- Orthopedic
- Cosmetic
- Pharmaceutical
Hyaluronic Acid Raw Material Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Drug Delivery
- Medical Device Coating
- Biomaterials And Implants
- Cell And Tissue Preservation
- Surgical Adhesion Prevention
- Orthopedics
- Bone Regeneration
- Viscosupplements
- Ophthalmology
- Contact Lens
- Cataract Surgery
- Aqueous Eye Drop
- Dermatology
- Dermal Filler
- Intradermal
- Wound Healing
Hyaluronic Acid Raw Material Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Cosmetic Clinics
- Hospitals
- Other
Hyaluronic Acid Raw Material Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Hyaluronic Acid Raw Material Market: Grade Estimates & Trend Analysis
8. Hyaluronic Acid Raw Material Market: Application Estimates & Trend Analysis
9. Hyaluronic Acid Raw Material Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Hyaluronic Acid Raw Material Market
12. Europe Global Hyaluronic Acid Raw Material Market
13. Asia Pacific Global Hyaluronic Acid Raw Material Market
14. Latin America Global Hyaluronic Acid Raw Material Market
15. MEA Global Hyaluronic Acid Raw Material Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Zimmer Biomet
- Sanofi
- AbbVie Inc.
- Smith+Nephew
- SEIKAGAKU CORPORATION
- Anika Therapeutics Inc.
- Lifecore Biomedical Inc.
- F. Hoffmann-La Roche Ltd.
- Ferring B.V.
- Salix Pharmaceuticals
- LG Chem
- Maruha Nichiro Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 7.05 Billion |
| Forecasted Market Value ( USD | $ 14.23 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
